Market closed
Nuvectis Pharma, Inc./$NVCT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nuvectis Pharma, Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Ticker
$NVCT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
13
Website
NVCT Metrics
BasicAdvanced
$195M
-
-$1.11
0.22
-
Price and volume
Market cap
$195M
Beta
0.22
52-week high
$10.71
52-week low
$5.87
Financial strength
Current ratio
2.092
Quick ratio
2.084
Management effectiveness
Return on assets (TTM)
-65.65%
Return on equity (TTM)
-173.41%
Valuation
Price to book
16.76
Price to tangible book (TTM)
16.76
Price to free cash flow (TTM)
-11.668
Growth
Earnings per share change (TTM)
-22.41%
3-year earnings per share growth (CAGR)
-28.36%
NVCT News
AllArticlesVideos
Nuvectis Pharma to Participate in the 37th Annual Roth Conference
GlobeNewsWire·4 weeks ago
Market News Alert: Nuvectis Pharma's NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation
Business Wire·1 month ago
Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Nuvectis Pharma, Inc. stock?
Nuvectis Pharma, Inc. (NVCT) has a market cap of $195M as of April 10, 2025.
What is the P/E ratio for Nuvectis Pharma, Inc. stock?
The price to earnings (P/E) ratio for Nuvectis Pharma, Inc. (NVCT) stock is 0 as of April 10, 2025.
Does Nuvectis Pharma, Inc. stock pay dividends?
No, Nuvectis Pharma, Inc. (NVCT) stock does not pay dividends to its shareholders as of April 10, 2025.
When is the next Nuvectis Pharma, Inc. dividend payment date?
Nuvectis Pharma, Inc. (NVCT) stock does not pay dividends to its shareholders.
What is the beta indicator for Nuvectis Pharma, Inc.?
Nuvectis Pharma, Inc. (NVCT) has a beta rating of 0.22. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
